Molecular and Epidemiological Investigation of Fluconazole-resistant Candida parapsilosis—Georgia, United States, 2021
Open Access
- 6 May 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (6) , ofae264
Abstract
Reports of fluconazole-resistant Candida parapsilosis bloodstream infections are increasing. We describe a cluster of fluconazole-resistant C. parapsilosis bloodstream infections identified in 2021 on routine surveillance by the Georgia Emerging Infections Program in conjunction with the Centers for Disease Control and Prevention. Whole-genome sequencing was used to analyze C. parapsilosis bloodstream infections isolates. Epidemiological data were obtained from medical records. A social network analysis was conducted using Georgia Hospital Discharge Data. Twenty fluconazole-resistant isolates were identified in 2021, representing the largest proportion (34%) of fluconazole-resistant C. parapsilosis bloodstream infections identified in Georgia since surveillance began in 2008. All resistant isolates were closely genetically related and contained the Y132F mutation in the ERG11 gene. Patients with fluconazole-resistant isolates were more likely to have resided at long-term acute care hospitals compared with patients with susceptible isolates (p-value 0.01). There was a trend towards increased mechanical ventilation and prior azole use in patients with fluconazole-resistant isolates. Social network analysis revealed that patients with fluconazole-resistant isolates interfaced with a distinct set of healthcare facilities centered around two long-term acute care hospitals compared with patients with susceptible isolates. WGS results showing that fluconazole-resistant C. parapsilosis isolates from Georgia surveillance demonstrated low genetic diversity compared with susceptible isolates and their association with a facility network centered around two long-term acute care hospitals suggests clonal spread of fluconazole-resistant C. parapsilosis. Further studies are needed to better understand the sudden emergence and transmission of fluconazole-resistant C. parapsilosis.Keywords
Funding Information
- US CDC
- Oak Ridge Institute for Science and Education
This publication has 34 references indexed in Scilit:
- Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care SurfaceJournal of Clinical Microbiology, 2017
- Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unitBMC Infectious Diseases, 2016
- Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical SpecimensMycopathologia, 2015
- Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a U.S. Surveillance SystemAntimicrobial Agents and Chemotherapy, 2015
- Genetic determinants of virulence – Candida parapsilosisRevista Iberoamericana de Micologia, 2014
- Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in IsraelClinical Microbiology and Infection, 2013
- Candida parapsilosis, an Emerging Fungal PathogenClinical Microbiology Reviews, 2008
- Epidemiologic and Molecular Characterization of an Outbreak of Candida parapsilosis Bloodstream Infections in a Community HospitalJournal of Clinical Microbiology, 2004
- Neonatal Candida parapsilosis outbreak with a high case fatality rateThe Pediatric Infectious Disease Journal, 1995
- Nosocomial acquisition of Candida parapsilosis: An epidemiologic studyThe American Journal of Medicine, 1993